Finance

Beta
Lists
IMRX:NASDAQ
Immuneering Corp
$5.11
-4.66%
(-0.25) 1D
$5.11
0.00% (0.00)
After hours
Closed: Jul 10, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for IMRX...
Open
$5.33
High
$5.33
Low
$5.00
Mkt. cap
330.60M
Avg. vol.
1.98M
Volume
827.74K
52-wk high
$10.08
52-wk low
$2.90
EPS
-$1.17
Beta
0.41
Shares outstanding
64.70M
No. of employees
55
Open
$5.33
High
$5.33
Low
$5.00
Mkt. cap
330.60M
Avg. vol.
1.98M
Volume
827.74K
52-wk high
$10.08
52-wk low
$2.90
EPS
-$1.17
Beta
0.41
Shares outstanding
64.70M
No. of employees
55
News stories
From sources across the web
About Immuneering Corp
CEO-
Employees55
Founded2008
Headquarters-
SectorBiotechnology
Websiteimmuneering.com
Analyst ratings
Based on 5 analysts giving stock ratings to IMRX in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for IMRX in the last 3 months.
Highest
Current $5.11
$20.00 (+291.39%)
Average
$14.40 (+181.80%)
Lowest
$11.00 (+115.26%)
Analyst
Recommendation
Action
Price target
Projected
Date
Li Watsek
Cantor Fitzgerald
Buy
Initiated
$17.00
+232.7%
07/08/2026
Graig Suvannavejh
Mizuho Securities
Buy
Reiterated
$12.00
+134.8%
06/16/2026
Ami Fadia
Needham
Buy
Maintained
$11.00
+115.3%
06/02/2026
Geulah Livshits
Chardan Capital
Buy
Reiterated
$20.00
+291.4%
05/19/2026
Allison Bratzel
Piper Sandler
Buy
Maintained
$12.00
+134.8%
04/21/2026
Jay Olson
Oppenheimer
Buy
Reiterated
$30.00
+487.1%
03/09/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
10.45M
10.87M
9.25M
10.65M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.30M
4.51M
4.49M
4.68M
Operating expense
14.76M
15.38M
13.75M
15.34M
Total operating expenses
14.76M
15.38M
13.75M
15.34M
Operating income
-14.76M
-15.38M
-13.75M
-15.34M
Other non operating income
-
-
155.92K
109.01K
EBT including unusual items
-14.43M
-14.96M
-11.58M
-13.46M
EBT excluding unusual items
-14.43M
-14.96M
-11.74M
-13.87M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-14.43M
-14.96M
-11.58M
-13.46M
Net profit margin
-
-
-
-
Earnings per share
-0.40
-0.38
-0.18
-0.21
Interest and investment income
324.01K
415.83K
1.86M
1.36M
Interest expense
-
-
-
-
Net interest expenses
324.01K
415.83K
1.86M
1.36M
Depreciation and amortization charges
-
-
-
-
EBITDA
-14.67M
-15.29M
-13.67M
-15.25M
Gain or loss from assets sale
-
-
2.09K
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer